Occupation and risk of primary Fallopian tube carcinoma in Nordic countries

International Journal of Cancer

Volumn 131, Issue 1, 2012, Pages 186-192

  Riska, A ^a   Martinsen, J I ^b   Kjaerheim, K ^b   Lynge, E ^c   Sparen, P ^d   Tryggvadottir, L ^e   Weiderpass, E ^b,d,f,g   Pukkala, E ^h,i  

^a UNIVERSITY OF HELSINKI   (Finland)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ICELANDIC CANCER REGISTRY   (Iceland)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g UNIVERSITY OF TROMSØ   (Norway)

^h FINNISH CANCER REGISTRY   (Finland)

ⁱ UNIVERSITY OF TAMPERE   (Finland)

Author keywords

cancer; cohort; epidemiology; Nordic; occupation; primary Fallopian tube carcinoma; standardized incidence ratio; women

Indexed keywords

ADULT; AGRICULTURAL WORKER; ARTICLE; ARTISTIC WORKER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHEMICAL PROCESS WORKER; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DENMARK; FEMALE; FINLAND; FOLLOW UP; HAIRDRESSER; HIGH RISK PATIENT; HUMAN; ICELAND; MAJOR CLINICAL STUDY; NORWAY; NURSE; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OFFICE WORKER; PACKER; PAINTER; PRIMARY FALLOPIAN TUBE CARCINOMA; PRINTING; PRIORITY JOURNAL; SHOP WORKER; SMELTING WORKER; STANDARDIZED INCIDENCE RATIO; SWEDEN; UTERINE TUBE CARCINOMA; WELDING; WORKER;

ADULT; FALLOPIAN TUBE NEOPLASMS; FEMALE; FINLAND; HUMANS; ICELAND; INCIDENCE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK; SCANDINAVIA;

EID: 84860221255     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26337     Document Type: Article

References (47)

1. Baekelandt M, Jorunn Nesbakken A, Kristensen GB, Trope CG, Abeler VM,. Carcinoma of the Fallopian tube. Cancer 2000; 89: 2076-84.
2. Riska A, Leminen A, Pukkala E,. Sociodemographic determinants of incidence of primary Fallopian tube carcinoma, Finland 1953-97. Int J Cancer 2003; 104: 643-5.
3. Rosenblatt KA, Weiss NS, Schwartz SM,. Incidence of malignant Fallopian tube tumours. Gynecol Oncol 1989; 35: 236-9.
4. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, Køtlum JE, O'lafsdõttir E, Pukkala E, Storm HH,. NORDCAN: cancer incidence, mortality, prevalence and prediction in the Nordic countries, Version 3.6 (April 2010). Association of the Nordic Cancer Registries. Danish Cancer Society 2010. Available at:.
5. Benoit MF, Hannigan EV,. A 10-year review of primary Fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. Int J Gynecol Cancer 2006; 16: 29-35.
6. Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G,. Analysis of treatment failures and survival of patients with Fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol 2001; 81: 150-9.
7. Riska A, Sund R, Pukkala E, Gissler M, Leminen A,. Parity, tubal sterilization, hysterectomy and risk of primary Fallopian tube carcinoma in Finland, 1975-2004. Int J Cancer 2007; 120: 1351-4.
8. Vicus D, Finch A, Rosen B, Fun I, Bradley L, Cass I, Sun P, Karlan B, McLaughlin J, Narod SA,; Hereditary Ovarian Cancer Clinical Study Group. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. Gynecol Oncol 2010; 118: 155-9.
9. Jordan S, Green A, Whiteman D, Moore S, Bain C, Gertig D, Webb P,; for the Australian Cancer Group (ovarian cancer) and the Australian Ovarian Cancer Study Group. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiologic analysis. Int J Cancer 2008; 122: 1598-603.
10. Riska A, Finne P, Koskela P, Alfthan H, Jalkanen J, Lehtinen M, Sorvari T, Stenman U, Paavonen J, Leminen A,. Human papillomavirus infections and primary Fallopian tube carcinoma: a seroepidemiological study. BJOG 2007; 114: 425-9.
11. Gungor T, Keskin HL, Zergeroglu S, Keskin EA, Yalcin H, Aydogdu T, Kucukozkan T,. Tuberculous salpingitis in two of five primary Fallopian tube carcinomas. J Obstet Gynaecol 2003; 23: 193-5.
12. Teppo L, Pukkala E, Lehtonen M,. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 365-9.
13. Larsen IK, SmÃstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Møller B,. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218-31.
14. Barlow L, Westergren K, Holmberg L, Talback M,. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009; 48: 27-33.
15. Storm HH, Manders T, Spørgel P, Bang S, Jensen OM,. Cancer incidence in Denmark 1987. Copenhagen (Denmark): Danish Cancer Society [Kræftens Bekæmpelse], 1990.
16. Vidarsdottir H, Stefansdottir S, Jonsdottir A, Jonasson JG, Trggvadottir L,. Completeness and accuracy of cancer registration in Iceland. Internal report of Icelandic Cancer Registry. Reykjavik (Iceland): Krabbameinsskra' I'slands, 2008 (In Icelandic).
17. Pukkala E, Martinsen J, Lynge E, Gunnarsdottir H, Sparen P, Tryggvadottir L, Weiderpass E, Kjaerheim K,. Occupation and cancer-follow-up of 15 million people in five Nordic countries. Acta Oncol 2009; 48: 646-790.
18. Pukkala E,. Biobanks and registers in epidemiological research on cancer. In:, Dillner J, editor. Methods in biobanking. Methods in molecular biology, 2011, Volume 675. Totowa, Humana Press 2011, pp. 61-112. DOI: 10.1007/978-1-59745-423-0-3.
19. Meurman LO, Pukkala E, Hakama M,. Incidence of cancer among anthophyllite asbestos miners in Finland. Occup Environ Med 1994; 51: 421-5.
20. Lynge E,. Dødelighet og erhverv 1970-75. Statistiske undersøgelser [Mortality and occupation 1970-75. Statistical investigations], vol. 37. Copenhagen (Denmark): Danmarks Statistik, 1979 (Danish).
21. Notkola V, Pajunen A, Leino-Arjas P,. Occupational mortality by cause in Finland 1971-1991 and occupational mobility. SVT health, vol 1. Helsinki (Finland): Statisics Finland, 1997.
22. Pukkala E,. Cancer risk by social class and occupation. A survey of 109,000 cancer cases among Finns of working age. In:, Wahrendorf J, editor. Contributions to epidemiology and biostatistics, vol. 7. Basel (Switzerland): Karger, 1995, pp. 3-12.
23. Mørkeberg H,. Fødslers placering i familiens livsforløb [Child-spacing in the family life cycle]. Socialforskningsinstituttet rapport No. 68. Copenhagen (Denmark): Socialforskningsinstituttet, 1976 (In Danish).
24. Hoem B,. Lärare föder fler barn [Teachers have more children]. Välfärdsbulletinen No. 3. Stockholm (Sweden): Statistiska centralbyrÃn, 1994. 17-9 (In Swedish).
25. Vicus D, Finch A, Cass I, Rosen B, Murphy J, Fan I, Royer R, McLaughlin J, Karlan B, Narod SA,. Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube. Gynecol Oncol 2010; 118: 299-302.
26. Manzoli L, Di Giovanni P, Del Luca L, De Aloysio D, Festi D, Capodicasa S, Monastra G, Romano F, Staniscia T,. Use of hormone replacement therapy in Italian women aged 50-70. Maturitas 2004; 49: 241-51.
27. Lambert L, Straton J, Knuiman M, Bartholomew H,. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia. J Epidemiol Community Health 2003; 57: 294-300.
28. Topo P, Luoto R, Hemminki E, Uutela A,. Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland. Maturitas 1999; 32: 141-5.
29. Topo P, Koster A, Holte A, Collins A, Landgren BM, Hemminki E, Uutela A,. Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas 1995, 22: 89-95.
30. Costantini AS, Pirastu R, Lagorio S, Miligi L, Costa G,. Studying cancer among female workers: Methods and preliminary results from a record-linkage system in Italy. J Occup Med 1994; 36: 1180-6.
31. IARC. Occupational exposures of hairdressers and barbers and personal use of hair colorants, some hair dyes, cosmetic colorants, industrial dyestuffs and aromatic amines. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 57. Lyon, France: IARC, 1993.
32. Czene K, Tiikkaja S, Hemminki K,. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer 2003; 105: 108-12.
33. Pukkala E, Nokso-Koivisto P, Roponen P,. Changing cancer risk pattern among Finnish hairdressers. Int Arch Occup Environ Health 1992; 64: 39-42.
34. Boffetta P, Andersen A, Lynge E, Barlow L, Pukkala E,. Employment as hairdresser and risk of ovarian cancer and non-Hodgkin's lymphomas among women. J Occup Med 1994; 36: 61-5.
35. Vasama-Neuvonen K, Pukkala E, Paakkulainen H, Mutanen P, Weiderpass E, Boffetta P, Shen N, Kauppinen T, Vainio H, Partanen T,. Ovarian cancer and occupational exposures in Finland. Am J Ind Med 1999; 36: 83-9.
36. Shields T, Gridley G, Moradi T, Adami J, Plato N, Dosemeci M,. Occupational exposures and the risk of ovarian cancer in Sweden. Am J Ind Med 2002; 42: 200-13.
37. Mader RM, Rizovski B, Steger GG, Wachter A, Kotz R, Rainer H,. Exposure of oncologic nurses to methotrexate in the treatment of osteosarcoma. Arch Environ Health 1996; 51: 310-4.
38. Stellman JM, Zoloth SR,. Cancer chemotherapeutic agents as occupational hazards: a literature review. Cancer Invest 1986; 4: 127-35.
39. Hewitt JB, Misner ST, Levin PF,. Health hazards of nursing: Identifying workplace hazards and reducing risks. AWHONNS Clin Issues Perinat Womens Health Nurs 1993; 4: 320-7.
40. Kjaer TK, Hansen J,. Cancer incidence among large cohort of female Danish registered nurses. Socioeconomic status and sterilization. Scand J Work Environ Health 2009; 35: 446-53.
41. Lie JA, Andersen A, Kjaerheim K,. Cancer risk among 43000 Norwegian nurses. Scand J Work Environ Health 2007; 33: 66-73.
42. Sala M, Dosemeci M, Zahm SH,. A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 US states. J Occup Environ Med 1998; 40: 632-9.
43. Petralia SA, Dosemeci M, Adams EE, Zahm SH,. Cancer mortality among women employed in health care occupations in 24 US States, 1984-1993. Am J Ind Med 1999; 36: 159-65.
44. Shen N, Weiderpass E, Anttila A, Goldberg MS, Vasama-Neuvonen KM, Boffetta P, Vainio HU, Partanen TJ,. Epidemiology of occupational and environmental risk factors related to ovarian cancer. Scand J Work Environ Health 1998; 24: 175-82.
45. Pukkala E, Notkola V,. Cancer incidence among Finnish farmers, 1979-93. Cancer Causes Control 1997; 8: 25-33.
46. Tavassoli FA, Devilee P, editors. World health organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
47. Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D,. The Fallopian tube: primary site of most pelvic high-grade serour carcinomas. Int J Gynecol Cancer 2009; 19: 58-64.